18 results
6-K
EX-99.1
STVN
Stevanato Group Spa
2 Aug 23
Current report (foreign)
9:32am
.
Pharmaceutical innovation is driving advancements in more complex biologic drugs and paving the way for new therapies that address chronic diseases, co
6-K
EX-99.3
STVN
Stevanato Group Spa
24 May 23
Current report (foreign)
9:47am
, chronic obstructive pulmonary disease (COPD) and other respiratory-related diseases. Licensed from inhalation specialist, Iconovo, the device
6-K
EX-99.1
STVN
Stevanato Group Spa
10 Nov 22
Current report (foreign)
5:02pm
, such as the growth in biologics and biosimilars, the rise of chronic diseases, pharmaceutical innovation, and the self-administration of treatments.
We … , the increasing incidence of chronic disease, and the shift towards the self-administration of medicines.
Our customers are making groundbreaking strides
6-K
EX-99.1
STVN
Stevanato Group Spa
8 Nov 22
Current report (foreign)
6:53am
towards injectable delivery formats is boosted by favorable macro trends such as: growth in biologics and biosimilars rise of chronic disease pharmaceutical … in biologics and biosimilars dovetail with the macro trends of: aging populations, increasing incidence of chronic disease, and shift towards the self
6-K
EX-99.1
ycq8 cmd8d2lb7v5
13 May 22
Stevanato Earnings Call
6:20am
6-K
EX-99.2
umrbfboupsm144l 16
6 May 22
Ordinary and Extraordinary Shareholders’ Meeting
6:07am
20-F/A
eegm dhdq
5 Apr 22
Annual report (foreign) (amended)
7:14am
6-K
EX-99.1
huqikapqfc7gduxd
11 Mar 22
Current report (foreign)
6:59am
20-F
c4dokveh kizeoazx
8 Mar 22
Annual report (foreign)
6:50am
6-K
EX-99.1
v956d
8 Mar 22
Current report (foreign)
6:44am
6-K
EX-99.1
s28owt3
8 Mar 22
Stevanato Group Reports Record 2021 Revenue of €843.9 million
6:39am
424B4
bmiikybg7c7vn3t9z
16 Jul 21
Prospectus supplement with pricing info
2:18pm
F-1/A
j1izt11ert
12 Jul 21
Registration statement (foreign) (amended)
7:22am
F-1/A
oza 1k8o0orhurh5nc
7 Jul 21
Registration statement (foreign) (amended)
9:59am
F-1
15t41w0t
21 Jun 21
Registration statement (foreign)
8:54am
DRS/A
5bc 4s35k2m37
30 Apr 21
Draft registration statement (amended)
12:00am
DRS
qvr414vq1pbw
22 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next